|
Volumn 49, Issue 12, 2005, Pages 5190-5191
|
Orally administered recombinant metallo-β-lactamase preserves colonization resistance of piperacillin-tazobactam-treated mice [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PIPERACILLIN;
PIPERACILLIN PLUS TAZOBACTAM;
RECOMBINANT ENZYME;
RECOMBINANT METALLO BETA LACTAMASE;
TARGETED RECOMBINANT BETA LACTAMASE 2;
TAZOBACTAM;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIBIOTIC RESISTANCE;
BACILLUS CEREUS;
BACILLUS SUBTILIS;
BACTERIAL COLONIZATION;
BACTERIAL GROWTH;
BACTERIAL STRAIN;
BACTERIUM CULTURE;
BACTERIUM ISOLATE;
COLONY FORMING UNIT;
CONTROLLED STUDY;
FEMALE;
LETTER;
MICROFLORA;
MOUSE;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
VANCOMYCIN RESISTANT ENTEROCOCCUS;
ADMINISTRATION, ORAL;
ANIMALS;
ANTI-BACTERIAL AGENTS;
BACTERIA;
BETA-LACTAM RESISTANCE;
BETA-LACTAMASES;
DRUG SYNERGISM;
MICE;
PENICILLANIC ACID;
PIPERACILLIN;
|
EID: 28844502692
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.49.12.5190-5191.2005 Document Type: Letter |
Times cited : (20)
|
References (5)
|